Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance

2019/07/25 by Stefan P. Brugger, Stefan Brugger, Ilinca Angelescu +6 · 27 citations
Medicine · Neuroscience · #Schizophrenia research and treatment #Neurotransmitter Receptor Influence on Behavior #Neural and Behavioral Psychology Studies

paper · doi:10.1016/j.biopsych.2019.07.008

Citations

• Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

Cited by

• On the Relationship between Treatment Effect Heterogeneity and the\n Variability Ratio Effect Size Statistic
• Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
• Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. [europepmc]
• Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients. [europepmc]
• Perspective: Solving the Heterogeneity Conundrum of TSPO PET Imaging in Psychosis. [europepmc]
• Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia. [europepmc]
• The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis. [europepmc]
• Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease. [europepmc]
• Mapping working memory-specific dysfunction using a transdiagnostic approach. [europepmc]
• How changes in dopamine D2 receptor levels alter striatal circuit function and motivation. [europepmc]
• Recent Advances and Future Directions in Brain MR Imaging Studies in Schizophrenia: Toward Elucidating Brain Pathology and Developing Clinical Tools. [europepmc]
• Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis. [europepmc]
• Neuromelanin-Sensitive Magnetic Resonance Imaging in Schizophrenia: A Meta-Analysis of Case-Control Studies. [europepmc]
• New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics. [europepmc]
• Compositional and functional alterations in the oral and gut microbiota in patients with psychosis or schizophrenia: A systematic review. [europepmc]
• Schizophrenia Increases Variability of the Central Antioxidant System: A Meta-Analysis of Variance From MRS Studies of Glutathione. [europepmc]
• A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia. [europepmc]
• Striatal dopamine dissociates methylphenidate effects on value-based versus surprise-based reversal learning. [europepmc]
• The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia. [europepmc]
• The effects of social isolation stress and discrimination on mental health. [europepmc]
• Magnetic resonance imaging of the dopamine system in schizophrenia - A scoping review. [europepmc]
• Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal. [europepmc]
• Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies. [europepmc]
• Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort. [europepmc]
• Neurostructural subgroup in 4291 individuals with schizophrenia identified using the subtype and stage inference algorithm. [europepmc]
• Belief Updating in Subclinical and Clinical Delusions. [europepmc]
• Quantitative evidence synthesis: a practical guide on meta-analysis, meta-regression, and publication bias tests for environmental sciences. [europepmc]